BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

19 related articles for article (PubMed ID: 38519268)

  • 1. Chronological alterations in de novo malignancies after living-donor liver transplantation: A cohort study of 1781 recipients using annual comparisons of standardized incidence ratios.
    Tajima T; Hata K; Tanaka K; Iyama N; Kusakabe J; Kageyama S; Ogawa E; Okamoto T; Haga H; Uemoto S; Hatano E
    J Hepatobiliary Pancreat Sci; 2024 Jun; ():. PubMed ID: 38845404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De Novo Malignancy After Adult-to-Adult Living Donor Liver Transplantation: A Single-Center Long-Term Experience.
    Masuda Y; Mita A; Ohno Y; Kubota K; Notake T; Shimizu A; Soejima Y
    Transplant Proc; 2023 May; 55(4):952-955. PubMed ID: 37088616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretransplant Hepatic Malignancy Increases Risk of De Novo Malignancy after Liver Transplantation.
    Park GC; Hwang S; Ahn CS; Kim KH; Moon DB; Ha TY; Song GW; Jung DH; Yoon YI; Cho HD; Kwon JH; Chung YK; Kang SH; Choi JU; Jung IJ; Lee SG
    J Korean Med Sci; 2020 Mar; 35(11):e69. PubMed ID: 32193900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De Novo Malignancy Following Adult-to-Adult Living Donor Liver Transplantation Focusing on Posttransplantation Lymphoproliferative Disorder.
    Mizuno S; Hayasaki A; Ito T; Fujii T; Iizawa Y; Kato H; Murata Y; Tanemura A; Kuriyama N; Azumi Y; Kishiwada M; Usui M; Sakurai H; Isaji S
    Transplant Proc; 2018 Nov; 50(9):2699-2704. PubMed ID: 30401380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retransplantation After Living Donor Liver Transplantation: Data from the Adult to Adult Living Donor Liver Transplantation Study.
    Braun HJ; Grab JD; Dodge JL; Syed SM; Roll GR; Schwab MP; Liu IH; Glencer AC; Freise CE; Roberts JP; Ascher NL
    Transplantation; 2021 Jun; 105(6):1297-1302. PubMed ID: 33347261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Factors of De Novo Malignancies After Living-Donor Liver Transplantation: A Single-Center Experience.
    Wahab MA; Abdel-Khalek EE; Elshoubary M; Yassen AM; Salah T; Sultan AM; Fathy O; Elmorshedi M; Shiha U; Elsadany M; Adly R; Samy M; Shehta A
    Transplant Proc; 2021 Mar; 53(2):636-644. PubMed ID: 33549346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignancy After Living Donor Liver Transplantation.
    Kobayashi T; Miura K; Ishikawa H; Sakata J; Takizawa K; Hirose Y; Toge K; Saito S; Abe S; Kawachi Y; Ichikawa H; Shimada Y; Takahashi Y; Wakai T; Kinoshita Y
    Transplant Proc; 2024 Apr; 56(3):660-666. PubMed ID: 38519268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes after ABO-incompatible liver transplantation: A systematic review and meta-analysis.
    Gan K; Li Z; Bao S; Fang Y; Wang T; Jin L; Ma M; Deng L; Peng Y; Li N; Zeng Z; Huang H
    Transpl Immunol; 2021 Dec; 69():101476. PubMed ID: 34601097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Operative outcomes of adult living donor liver transplantation and deceased donor liver transplantation: a systematic review and meta-analysis.
    Wan P; Yu X; Xia Q
    Liver Transpl; 2014 Apr; 20(4):425-36. PubMed ID: 24478109
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.